These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 203464)

  • 1. Congenital generalized lipodystrophy with insulin-resistant diabetes.
    Kodama S; Kasuga M; Seki A; Ninomiya M; Sakurai T; Morishita Y; Matsuo M; Matsuo T
    Eur J Pediatr; 1978 Jan; 127(2):111-9. PubMed ID: 203464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance in a child with Acanthosis nigricans type A.
    Mariani S; Pedone A; Meschi F; di Natale B; Caputo R; Broggi U; Chiumello G
    Acta Paediatr Scand; 1982 Jul; 71(4):667-70. PubMed ID: 7136687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin resistance with acanthosis nigricans: a case report].
    Fukushima N; Nohara Y; Fujita H; Endo M; Abe K; Matsuura N; Kosaka S; Satomi S
    Nihon Naibunpi Gakkai Zasshi; 1982 Jun; 58(6):807-16. PubMed ID: 6749565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased binding of insulin to its receptor in patients with congenital generalized lipodystrophy.
    Oseid S; Beck-Nielsen H; Pedersen O; Sovik O
    N Engl J Med; 1977 Feb; 296(5):245-8. PubMed ID: 831106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and acanthosis nigricans. Report of a case with antibodies to insulin receptors.
    Pulini M; Raff SB; Chase R; Gordon EE
    Ann Intern Med; 1976 Dec; 85(6):749-51. PubMed ID: 1087135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin requirements in lipodystrophic diabetes.
    Mora PF; Ramirez LC; Lender D; Raskin P
    Diabet Med; 1993 Nov; 10(9):863-5. PubMed ID: 8281734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of insulin resistance associated with acanthosis nigricans.
    Fukushima N; Matsuura N; Nohara Y; Fujita H; Endo M; Abe K; Kosaka S; Satomi S
    Tohoku J Exp Med; 1984 Oct; 144(2):129-38. PubMed ID: 6393448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital generalized lipodystrophy in a 4-month-old infant.
    Lee IH; Chen HL; Jeng YM; Cheng MT; Tsao LY; Chang MH
    J Formos Med Assoc; 2001 Sep; 100(9):623-7. PubMed ID: 11695279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial insulin resistance and acanthosis nigricans.
    Praptono R; Sunartini ; Djunduah ; Sadjimin T
    Paediatr Indones; 1990; 30(7-8):213-21. PubMed ID: 2075024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipodystrophy of limbs associated with insulin resistance.
    Lillystone D; West RJ
    Arch Dis Child; 1975 Sep; 50(9):737-9. PubMed ID: 1190824
    [No Abstract]   [Full Text] [Related]  

  • 11. A possible role of circulating lipoprotein-triglycerides in the increase in concentration of free fatty acids and in insulin resistance in "total" lipodystrophy.
    Naito C; Togawa K
    J Clin Endocrinol Metab; 1974 Dec; 39(6):1030-7. PubMed ID: 4430703
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipoatrophic diabetes.
    Sasaki T; Ono H; Nakajima H; Sugimoto J
    J Dermatol; 1992 Apr; 19(4):246-9. PubMed ID: 1607489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
    Nauck MA; Sauerwald A; Ritzel R; Holst JJ; Schmiegel W
    Diabetes Care; 1998 Nov; 21(11):1925-31. PubMed ID: 9802745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital generalized lipodystrophy and experimental lipoatrophic diabetes in rabbits treated successfully with fenfluramine.
    Trygstad O; Foss I
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):436-48. PubMed ID: 577333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy.
    Park JY; Chong AY; Cochran EK; Kleiner DE; Haller MJ; Schatz DA; Gorden P
    J Clin Endocrinol Metab; 2008 Jan; 93(1):26-31. PubMed ID: 17940115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acanthosis nigricans and congenital total lipodystrophy. Associated anomalies observed in two siblings.
    Brubaker MM; Levan NE; Collipp PJ
    Arch Dermatol; 1965 Apr; 91(4):320-5. PubMed ID: 9626078
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin resistant diabetes showing anti-insulin receptor autoantibody with systemic scleroderma, acanthosis nigricans and total lipodystrophy (author's transl)].
    Sugawara H; Toyota T; Okuguchi F; Umezu M; Kai Y; Abe R; Maruhama Y; Goto Y; Hanew K; Utsumi N
    Nihon Naika Gakkai Zasshi; 1980 Mar; 69(3):361-9. PubMed ID: 7381285
    [No Abstract]   [Full Text] [Related]  

  • 18. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
    Keller U; Müller R; Berger W
    Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice.
    Ahrén B; Simonsson E; Scheurink AJ; Mulder H; Myrsén U; Sundler F
    Metabolism; 1997 Jan; 46(1):97-106. PubMed ID: 9005977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance.
    Wilson DE; Chan IF; Stevenson KB; Horton SC; Schipke C
    J Clin Endocrinol Metab; 1983 Sep; 57(3):517-23. PubMed ID: 6348062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.